Jones Nathaniel T.
Transaction: 03/16/2026
SELL
Change
-1,000
Price
$12.40
Filing
03/18/2026
Type
SELL
Nuveen Real Asset Income and Growth Fund
JRI • Asset Management - Income
$12.14
▼ -0.07 (-0.57%)
Current price
EarningsLatest report: Dec 31, 2025
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$333.12M
Growth
12.0%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 112.6%Positive free cash flow · 0.71Consistent free cash flow · 4/5Reasonable earnings multiple · 7.6Manageable debt level · 0.47
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$12.14
Change-0.57%
Shares Out27.44M
Market Cap$333.12M
Enterprise Value$497.09M
52W Range11.67 - 14.27
Beta0.90
P/E4.46
P/S3.90
P/B0.91
P/FCF7.75
EV/Sales5.82
Price$12.14
Change-0.57%
Shares Out27.44M
Market Cap$333.12M
Enterprise Value$497.09M
52W Range11.67 - 14.27
Beta0.90
P/E4.46
P/S3.90
P/B0.91
P/FCF7.75
EV/Sales5.82
EV/EBITDA5.37
EV/FCF11.56
Earnings Yield22.40%
FCF Yield12.90%
Dividend Yield24.91%
Gross Margin87.11%
Oper. Margin131.91%
Profit Margin112.64%
Debt/Eq0.47
Current Ratio4.75
Quick Ratio4.75
Revenue 5Y11.95%
FCF 5Y9.44%
Volume179.64K
Avg Volume185.40K
Investment DNA
How strong this company looks for long-term investors
71
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
87/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
76/100
Why this score▼
Stable or improving margins · 112.6%Positive free cash flow · 0.71Consistent free cash flow · 4/5Reasonable earnings multiple · 7.6Manageable debt level · 0.47Healthy liquidity · 4.75
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Jones Nathaniel T.
Transaction: 03/16/2026
BUY
Change
+750
Price
$12.40
Filing
03/18/2026
Type
BUY
LAMB DAVID J
Transaction: 03/13/2026
BUY
Change
+1,968
Price
$12.40
Filing
03/17/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Jones Nathaniel T. | SELL | -1,000 | $12.40 | 03/16/2026 | 03/18/2026 |
| Jones Nathaniel T. | BUY | +750 | $12.40 | 03/16/2026 | 03/18/2026 |
| LAMB DAVID J | BUY | +1,968 | $12.40 | 03/13/2026 | 03/17/2026 |
| LAMB DAVID J | SELL | -7,872 | $12.40 | 03/13/2026 | 03/17/2026 |
| Castro Joseph | OTHER | 0 | Not reported | 10/16/2025 | 02/23/2026 |
| Page Robert Tanner | OTHER | 0 | Not reported | 09/10/2025 | 02/20/2026 |
| Kim James Shung-ook | OTHER | 0 | Not reported | 02/12/2025 | 02/21/2025 |
| Cardella Marc | OTHER | 0 | Not reported | 12/02/2024 | 12/03/2024 |
| Hauser Noah | OTHER | 0 | Not reported | 04/30/2024 | 04/30/2024 |
| Jones Nathaniel T. | BUY | +1,000 | $11.60 | 04/04/2024 | 04/04/2024 |
| Ramsay Mary Beth | OTHER | 0 | Not reported | 02/28/2024 | 03/11/2024 |
| Nelson James N III | OTHER | 0 | Not reported | 02/28/2024 | 03/08/2024 |
| Forrester Michael A | OTHER | 0 | Not reported | 01/01/2024 | 01/11/2024 |
| Boateng Joseph A | OTHER | 0 | Not reported | 01/01/2024 | 01/10/2024 |
| KENNY THOMAS J | OTHER | 0 | Not reported | 01/01/2024 | 01/10/2024 |
| STARR LOREN M | OTHER | 0 | Not reported | 01/01/2024 | 01/10/2024 |
| Stenersen Trey III | OTHER | 0 | Not reported | 08/04/2022 | 08/15/2022 |
| Black Brett | OTHER | 0 | Not reported | 06/01/2022 | 06/08/2022 |
| McCann John M. | OTHER | 0 | Not reported | 04/14/2022 | 04/21/2022 |
| Kerl Ben | OTHER | 0 | Not reported | 10/01/2021 | 10/01/2021 |